2007 Healthcare Patients Prescription 
World of DTC Marketing
JANUARY 5, 2021
percent in 2007-2008 to 39.6 Pharma should strive to get patients off some prescription drugs because they lost weight and are eating well, but we know that’s not going to happen. My doctor recently told me that she has stopped seeing patients who don’t take her advice on losing weight and exercising.
World of DTC Marketing
AUGUST 6, 2021
Over one-third struggle with basic health tasks, such as following prescription-drug directions. University of Connecticut, 2007.). When patients receive written health communication materials that don’t match their reading level, patient education is not effective. This is a huge opportunity for pharma to help patients.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
AUGUST 19, 2022
US startup Dr B – formed in 2021 to help match patients seeking a COVID-19 vaccine to suppliers with leftover stock – is branching out into antivirals with the help of an $8 million fundraising. The “visitless prescription” service will be available for free for people with low incomes, according to Dr B’s website.
Pharma Marketing Network
MAY 3, 2023
From influencing patient behavior to shaping the way healthcare providers prescribe medications, these advertisements play a crucial role in the pharmaceutical industry. However, the effects of these advertisements are not always positive, as they can also lead to overdiagnosis, overtreatment, and higher healthcare costs.
pharmaphorum
OCTOBER 19, 2022
CVS Health recently acquired home healthcare agency, Signify Health , for a whopping $8 billion. With the biggest players across the healthcare industry interested in making an offer, I only expect the popularity and availability of home healthcare to grow from here. It’s a big win for the company.
Pharmaceutical Technology
JULY 23, 2008
It has boosted anti-tumour research by 60% since 2005, at a cost of $1.6bn, in the hope of increasing the share of company sales attributed to cancer drugs from the current level of 5% “There are a lot of patients that are suffering,” said Pfizer chief executive Jeffrey Kindler.
Expert insights. Personalized for you.
189 
Let's personalize your content